103 related articles for article (PubMed ID: 4361279)
61. Synthesis of virus-capsid antigen (VCA) enhanced by ultraviolet irradiation of a lymphoblastoid cell line carrying Epstein-Barr virus.
Lai PK; Mackay-Scollay EM; Alpers MP
J Gen Virol; 1973 Oct; 21():135-43. PubMed ID: 4361743
[No Abstract] [Full Text] [Related]
62. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
Wiels J; Lenoir GM; Fellous M; Lipinski M; Salomon JC; Tetaud C; Tursz T
Int J Cancer; 1982 Jun; 29(6):653-8. PubMed ID: 6286514
[TBL] [Abstract][Full Text] [Related]
63. An immunoperoxidase assay for the detection of specific IgA antibody in Epstein-Barr virus infections.
Cevenini R; Donati M; Rumpianesi F; Moroni A; Paolucci P
J Clin Pathol; 1984 Apr; 37(4):440-3. PubMed ID: 6323549
[TBL] [Abstract][Full Text] [Related]
64. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
65. Studies of Epstein-Barr virus (ebv)-associated nuclear antigen. I. assay in human lymphoblastoid cell lines by direct and indirect determination of 125I-IgG binding.
Brown TD; Ernberg I; Klein G
Int J Cancer; 1975 Apr; 15(4):606-16. PubMed ID: 166942
[TBL] [Abstract][Full Text] [Related]
66. Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV).
Yata J; Desgranges C; Nakagawa T; Favre MC; De-The G
Int J Cancer; 1975 Mar; 15(3):377-84. PubMed ID: 49325
[TBL] [Abstract][Full Text] [Related]
67. Effect of inhibition of DNA synthesis on Epstein--Barr virus induction by tumor promoters.
Yamamoto N; zur Hausen H
Virology; 1980 Feb; 101(1):104-10. PubMed ID: 6243817
[No Abstract] [Full Text] [Related]
68. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
Qualtiere LF; Pearson GR
Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099
[TBL] [Abstract][Full Text] [Related]
69. Synthesis of Epstein-Barr virus antigens and DNA in activated Burkitt somatic cell hybrids.
Glaser R; Nonoyama M; Decker B; Rapp F
Virology; 1973 Sep; 55(1):62-9. PubMed ID: 4353957
[No Abstract] [Full Text] [Related]
70. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging.
Jondal M
Clin Exp Immunol; 1977 Jul; 29(1):1-10. PubMed ID: 196801
[TBL] [Abstract][Full Text] [Related]
71. Specific in vitro binding of radiolabeled antibodies to cell surface antigens: interaction of antihuman thymocyte globulin with human target cells.
Garcia-Rinaldi R; Rossen RD; Hersh EM; Kormeier L; Butler WT
J Immunol Methods; 1976; 9(3-4):235-49. PubMed ID: 814167
[TBL] [Abstract][Full Text] [Related]
72. Epstein-Barr viral antigen in single cell clones of two human leukocytic lines.
Miller MH; Stitt D; Miller G
J Virol; 1970 Nov; 6(5):699-701. PubMed ID: 4320703
[TBL] [Abstract][Full Text] [Related]
73. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.
Okano M; Aya T; Mizuno F; Takada K; Osato T
Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328
[TBL] [Abstract][Full Text] [Related]
74. Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis.
Catalano MA; Carson DA; Slovin SF; Richman DD; Vaughan JH
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5825-8. PubMed ID: 230491
[TBL] [Abstract][Full Text] [Related]
75. Enzyme-linked immunosorbent assay for IgG antibodies to Epstein-Barr virus-associated early antigens and viral capsid antigen.
Dölken G; Weitzmann U; Boldt C; Bitzer M; Brugger W; Löhr GW
J Immunol Methods; 1984 Mar; 67(2):225-33. PubMed ID: 6323578
[TBL] [Abstract][Full Text] [Related]
76. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
Sairenji T; Nguyen QV; Woda B; Humphreys RE
J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
[TBL] [Abstract][Full Text] [Related]
77. The presence of the Epstein-Barr viral genome in human lymphoblastoid B-cell lines and its absence in a myeloma cell line.
Minowada J; Nonoyama M; Moore GE; Rauch AM; Pagano JS
Cancer Res; 1974 Aug; 34(8):1898-903. PubMed ID: 4366935
[No Abstract] [Full Text] [Related]
78. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
[TBL] [Abstract][Full Text] [Related]
79. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
Wasik M; Myc A; Matej H; Rudzka L
Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
[TBL] [Abstract][Full Text] [Related]
80. Epstein-Barr virus induction by a serum factor. I. Induction and cooperation with additional inducers.
Bauer G; Höfler P; Zur Hausen H
Virology; 1982 Aug; 121(1):184-94. PubMed ID: 6287718
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
